Behavioral profile of wild mice in the elevated plus-maze test for anxiety (Q42644507)

4 November 2017

title

Behavioral profile of wild mice in the elevated plus-maze test for anxiety (English)

1 reference

4 November 2017

1 reference

Holmes A

1

1 reference

4 November 2017

Parmigiani S

2

1 reference

4 November 2017

Ferrari PF

3

1 reference

4 November 2017

Palanza P

4

1 reference

4 November 2017

Rodgers RJ

5

1 reference

4 November 2017

language of work or name

English

0 references

publication date

1 December 2000

1 reference

4 November 2017

published in

Physiology & Behavior

1 reference

4 November 2017

volume

71

1 reference

4 November 2017

issue

5

1 reference

4 November 2017

page(s)

509-516

1 reference

A review of the validity and variability of the elevated plus-maze as an animal model of anxiety

4 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2800%2900373-5

7 January 2021

Animal models of ??anxiety??: where next?

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2800%2900373-5

7 January 2021

Reduced anxiety-like and cognitive performance in mice lacking the corticotropin-releasing factor receptor 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2800%2900373-5

7 January 2021

A Proposed Test Battery and Constellations of Specific Behavioral Paradigms to Investigate the Behavioral Phenotypes of Transgenic and Knockout Mice

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2800%2900373-5

7 January 2021

Decreased GABAA-receptor clustering results in enhanced anxiety and a bias for threat cues

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2800%2900373-5

7 January 2021

Elevated anxiety and antidepressant-like responses in serotonin 5-HT1A receptor mutant mice

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2800%2900373-5

7 January 2021

Increased anxiety and altered responses to anxiolytics in mice deficient in the 65-kDa isoform of glutamic acid decarboxylase.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2800%2900373-5

7 January 2021

5-HT1B receptor knock-out mice exhibit increased exploratory activity and enhanced spatial memory performance in the Morris water maze.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2800%2900373-5

7 January 2021

Increased anxiety of mice lacking the serotonin1A receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2800%2900373-5

7 January 2021

Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2800%2900373-5

7 January 2021

Overproduction of corticotropin-releasing factor in transgenic mice: a genetic model of anxiogenic behavior.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2800%2900373-5

7 January 2021

Dopamine D3 receptor mutant mice exhibit increased behavioral sensitivity to concurrent stimulation of D1 and D2 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2800%2900373-5

7 January 2021

Behavioural and pharmacological characterisation of the elevated "zero-maze" as an animal model of anxiety.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2800%2900373-5

7 January 2021

Ethopharmacological analysis of rat behavior on the elevated plus-maze.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2800%2900373-5

7 January 2021

Factor analysis of spatiotemporal and ethological measures in the murine elevated plus-maze test of anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2800%2900373-5

7 January 2021

Effects of weekly or daily exposure to the elevated plus-maze in male mice

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2800%2900373-5

7 January 2021

Responses of Swiss-Webster mice to repeated plus-maze experience: further evidence for a qualitative shift in emotional state?

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2800%2900373-5

7 January 2021

Utility of ethological analysis to overcome locomotor confounds in elevated maze models of anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2800%2900373-5

7 January 2021

Influence of spatial and temporal manipulations on the anxiolytic efficacy of chlordiazepoxide in mice previously exposed to the elevated plus-maze

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2800%2900373-5

7 January 2021

Ethological evaluation of the effects of acute and chronic buspirone treatment in the murine elevated plus-maze test: comparison with haloperidol.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2800%2900373-5

7 January 2021

Risk assessment behaviour: evaluation of utility in the study of 5-HT-related drugs in the rat elevated plus-maze test.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2800%2900373-5

7 January 2021

Comparative effects of novel 5-HT1A receptor ligands, LY293284, LY315712 and LY297996, on plus-maze anxiety in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2800%2900373-5

7 January 2021

Ethopharmacological analysis of 5-HT ligands on the rat elevated plus-maze

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2800%2900373-5

7 January 2021

Defense system psychopharmacology: an ethological approach to the pharmacology of fear and anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2800%2900373-5

7 January 2021

Differentiation of anxiolytic and panicolytic drugs by effects on rat and mouse defense test batteries

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2800%2900373-5

7 January 2021

Comparing different forms of male and female aggression in wild and laboratory mice: an ethopharmacological study.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2800%2900373-5

7 January 2021

Selection, evolution of behavior and animal models in behavioral neuroscience

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2800%2900373-5

7 January 2021

Defensive behaviors in wild and laboratory (Swiss) mice: the mouse defense test battery

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2800%2900373-5

7 January 2021

Exploration and predation models of anxiety: evidence from laboratory and wild species

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2800%2900373-5

7 January 2021

Effects of diazepam and buspirone on the behaviour of wild voles (Microtus socialis) in two models of anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2800%2900373-5

7 January 2021

Aggression and adaptation to the light-dark cycle: role of intrinsic and extrinsic control

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2800%2900373-5

7 January 2021

Antinociceptive effects of elevated plus-maze exposure: influence of opiate receptor manipulations.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2800%2900373-5

7 January 2021

Influence of social isolation, gender, strain, and prior novelty on plus-maze behaviour in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2800%2900373-5

7 January 2021

Thigmotaxis as a test for anxiolytic activity in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2800%2900373-5

7 January 2021

Anxiogenic stimuli in the elevated plus-maze.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2800%2900373-5

7 January 2021

Behavioural effects in mice of subchronic chlordiazepoxide, maprotiline and fluvoxamine. II. The elevated plus-maze.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2800%2900373-5

7 January 2021

The influence of open arm ledges and maze experience in the elevated plus-maze

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2800%2900373-5

7 January 2021

The ambivalent behaviour "stretched approach posture" in the rat as a paradigm to characterize anxiolytic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2800%2900373-5

7 January 2021

Behavioural and pharmacological characterisation of the canopy stretched attend posture test as a model of anxiety in mice and rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2800%2900373-5

7 January 2021

The use of a plus-maze to measure anxiety in the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2800%2900373-5

7 January 2021

One-trial tolerance to the anxiolytic effects of chlordiazepoxide in the plus-maze

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2800%2900373-5

7 January 2021

Effects of diazepam on behavioural and antinociceptive responses to the elevated plus-maze in male mice depend upon treatment regimen and prior maze experience

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2800%2900373-5

7 January 2021

"One-trial tolerance" to the anxiolytic actions of benzodiazepines in the elevated plus-maze, or the development of a phobic state?

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2800%2900373-5

7 January 2021

One-trial tolerance to the effects of chlordiazepoxide on the elevated plus maze may be due to locomotor habituation, not repeated drug exposure.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2800%2900373-5

7 January 2021

Trial 2 in the elevated plus-maze: a different form of fear?

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2800%2900373-5

7 January 2021

Influence of prior maze experience on behaviour and response to diazepam in the elevated plus-maze and light/dark tests of anxiety in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2800%2900373-5

7 January 2021

Gender bias in the preclinical psychopharmacology of anxiety: male models for (predominantly) female disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2800%2900373-5

7 January 2021

Sex effects in defensive behavior: baseline differences and drug interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2800%2900373-5

7 January 2021

Differences in fear motivated behaviors among inbred mouse strains

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2800%2900373-5

7 January 2021

Anxiolytic-like effects of yohimbine in the murine plus-maze: strain independence and evidence against alpha 2-adrenoceptor mediation.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2800%2900373-5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2800%2900373-5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2800%2900373-5

7 January 2021

Differential modulation of antipredator defensive behavior in Swiss-Webster mice following acute or chronic administration of imipramine and fluoxetine.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2800%2900373-5

7 January 2021

Further evidence that the mouse defense test battery is useful for screening anxiolytic and panicolytic drugs: effects of acute and chronic treatment with alprazolam

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2800%2900373-5

7 January 2021

5-HT1A agonists modulate mouse antipredator defensive behavior differently from the 5-HT2A antagonist pirenperone

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2800%2900373-5

7 January 2021

Species-specific behavior and acquisition of avoidance behavior in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2800%2900373-5

7 January 2021

10.1016/S0031-9384(00)00373-5

Identifiers

DOI

1 reference

4 November 2017

1 reference